Insider Trading History of Campbell Bradley L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Campbell Bradley L since year 2005. The trader's CIK number is 1400971. At the time of the last reporting, Campbell Bradley L was the Chief Operating Officer of Amicus Therapeutics, Inc. . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics, Inc. .

Note that in the past Campbell Bradley L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Campbell Bradley L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-01-15 FOLD Amicus Therapeutics, Inc. Sale 5,064 10.35 52,387
2020-01-09 FOLD Amicus Therapeutics, Inc. Option Ex 2,500 5.96 14,900
2020-01-09 FOLD Amicus Therapeutics, Inc. Sale 2,500 10.01 25,025
2020-01-02 FOLD Amicus Therapeutics, Inc. Sale 22,127 9.58 212,043
2020-01-02 FOLD Amicus Therapeutics, Inc. Option Ex 7,500 5.96 44,700
2019-07-03 PGNX Progenics Pharmaceuticals Inc Option Ex 12,000 4.89 58,679
2019-01-22 FOLD Amicus Therapeutics, Inc. Sale 36,000 11.81 425,124
2019-01-22 FOLD Amicus Therapeutics, Inc. Option Ex 36,000 10.36 372,960
2018-01-22 FOLD Amicus Therapeutics, Inc. Option Ex 32,500 10.21 331,825
2018-01-22 FOLD Amicus Therapeutics, Inc. Sale 32,500 15.92 517,367
2017-03-02 FOLD Amicus Therapeutics, Inc. Sale 49,050 8.00 392,400
2017-01-03 FOLD Amicus Therapeutics, Inc. Option Ex 100,000 .00 0
2016-01-04 FOLD Amicus Therapeutics, Inc. Option Ex 50,000 .00 0
2015-09-21 FOLD Amicus Therapeutics, Inc. Option Ex 13,001 16.78 218,208
2015-09-21 FOLD Amicus Therapeutics, Inc. Sale 13,001 16.78 218,208
2015-06-19 FOLD Amicus Therapeutics, Inc. Option Ex 13,000 13.26 172,419
2015-06-19 FOLD Amicus Therapeutics, Inc. Sale 13,000 13.26 172,419
2015-05-08 FOLD Amicus Therapeutics, Inc. Option Ex 50,000 .00 0
2015-05-11 FOLD Amicus Therapeutics, Inc. Sale 24,800 10.84 268,807
2015-03-20 FOLD Amicus Therapeutics, Inc. Sale 12,999 11.51 149,592
2015-03-20 FOLD Amicus Therapeutics, Inc. Option Ex 12,999 11.51 149,592
2014-11-25 FOLD Amicus Therapeutics, Inc. Buy 7,250 8.00 58,000
2014-11-25 FOLD Amicus Therapeutics, Inc. Sale 7,250 8.00 58,000
2014-08-25 FOLD Amicus Therapeutics, Inc. Buy 7,000 6.00 42,000
2014-08-25 FOLD Amicus Therapeutics, Inc. Sale 7,000 6.00 42,000
2014-08-20 FOLD Amicus Therapeutics, Inc. Buy 18,750 5.40 101,250
2014-08-20 FOLD Amicus Therapeutics, Inc. Sale 18,750 5.40 101,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Campbell Bradley L (Chief Operating Officer of Amicus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month